HealthVot

Live Markets

Loading markets...

Featured Stories

Breaking: FDA Clears Revolutionary XCSITE 'Brain-Tuning' Wearable for Rapid Depression Relief

Breaking: FDA Clears Revolutionary XCSITE 'Brain-Tuning' Wearable for Rapid Depression Relief

February 28, 2026

Vegetarian Diet Links to Lower Risk of 5 Cancers: Major 2026 Study

Vegetarian Diet Links to Lower Risk of 5 Cancers: Major 2026 Study

Shingles Vaccine Linked to Slower Biological Aging: USC Study Uncovers New 'Longevity Shot' Benefits

Shingles Vaccine Linked to Slower Biological Aging: USC Study Uncovers New 'Longevity Shot' Benefits

CDC 2026 Vaccine Overhaul: The New 3-Tiered Schedule & Legal Battles

CDC 2026 Vaccine Overhaul: The New 3-Tiered Schedule & Legal Battles

The 'Muscle Guard' Mandate: Why 2026 Research Makes Resistance Training Essential for GLP-1 Weight Loss

The 'Muscle Guard' Mandate: Why 2026 Research Makes Resistance Training Essential for GLP-1 Weight Loss

Fitness

The 'Muscle Guard' Mandate: Why 2026 Research Makes Resistance Training Essential for GLP-1 Weight Loss

The 'Muscle Guard' Mandate: Why 2026 Research Makes Resistance Training Essential for GLP-1 Weight Loss

XENOM Raises $15 Million to Launch ‘Decathlon of Fitness’ Global League

XENOM Raises $15 Million to Launch ‘Decathlon of Fitness’ Global League

Kidulting Fitness Revolution: Why Playground Games Are the Top Workout Trend of 2026

Kidulting Fitness Revolution: Why Playground Games Are the Top Workout Trend of 2026

The Rise of Japanese Walking: 2026’s Ultimate Longevity Hack

The Rise of Japanese Walking: 2026’s Ultimate Longevity Hack

Family

CDC 2026 Vaccine Overhaul: The New 3-Tiered Schedule & Legal Battles

CDC 2026 Vaccine Overhaul: The New 3-Tiered Schedule & Legal Battles

2026 CDC Vaccine Schedule: Core Protections & Shared Decision Model

2026 CDC Vaccine Schedule: Core Protections & Shared Decision Model

CDC: Childhood Obesity Hits Historic 21.1%, "Exceptionally Concerning" Say Experts

CDC: Childhood Obesity Hits Historic 21.1%, "Exceptionally Concerning" Say Experts

CDC 2026 Vaccine Schedule Overhaul: The Ultimate Guide to the New Tiered System

CDC 2026 Vaccine Schedule Overhaul: The Ultimate Guide to the New Tiered System

Nutrition

Vegetarian Diet Links to Lower Risk of 5 Cancers: Major 2026 Study

Vegetarian Diet Links to Lower Risk of 5 Cancers: Major 2026 Study

Vegetarian Diet Cancer Risk: Landmark Study Reveals Lower Risk for 5 Key Cancers

Vegetarian Diet Cancer Risk: Landmark Study Reveals Lower Risk for 5 Key Cancers

Red Meat and Tallow: New 2025-2030 U.S. Dietary Guidelines Shake Up Nutrition Science

Red Meat and Tallow: New 2025-2030 U.S. Dietary Guidelines Shake Up Nutrition Science

Vegetarian Diet Links to Lower Risk of 5 Cancers in Landmark 2026 Study

Vegetarian Diet Links to Lower Risk of 5 Cancers in Landmark 2026 Study

Healthy Aging

Shingles Vaccine Linked to Slower Biological Aging: USC Study Uncovers New 'Longevity Shot' Benefits

Shingles Vaccine Linked to Slower Biological Aging: USC Study Uncovers New 'Longevity Shot' Benefits

Beyond Disease: First-of-its-Kind $38M Study to Test Drugs for Human Longevity Launches Nationwide

Beyond Disease: First-of-its-Kind $38M Study to Test Drugs for Human Longevity Launches Nationwide

Shingles Vaccine Linked to Slower Biological Aging: 2026 Study Results

Shingles Vaccine Linked to Slower Biological Aging: 2026 Study Results

Breaking: Shingles Vaccine Found to Dramatically Slow Biological Aging

Breaking: Shingles Vaccine Found to Dramatically Slow Biological Aging

Mental Health

Breaking: FDA Clears Revolutionary XCSITE 'Brain-Tuning' Wearable for Rapid Depression Relief

Breaking: FDA Clears Revolutionary XCSITE 'Brain-Tuning' Wearable for Rapid Depression Relief

FDA Approves XCSITE: The Brain-Tuning Mesh for Depression

FDA Approves XCSITE: The Brain-Tuning Mesh for Depression

Breaking: Cannabis Use Linked to Doubling of Anxiety and Depression Rates in Landmark Study

Breaking: Cannabis Use Linked to Doubling of Anxiety and Depression Rates in Landmark Study

FDA Approves Bysanti: Breakthrough Schizophrenia & Bipolar I Treatment

FDA Approves Bysanti: Breakthrough Schizophrenia & Bipolar I Treatment